Observational studyMedicina (Kaunas, Lithuania)2026
HER3 and FOLR1 Expression as Actionable Targets in High-Grade Serous Ovarian Carcinoma: Prognostic and Therapeutic Implications.
Nurhan Onal Kalkan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.